The effectiveness of the integrated use of gepadif, ezetrol and fosinopril in the nonalcoholic steatohepatitis in patients with hypertension stage II by O. S. Khukhlina, O. E. Mandryk, A. A. Antoniv

Subjects: “…nonalcoholic steatohepatitis…”
Get full text

Clinical and pathogenetic differences of the course of flow nonalcoholic steatohepatitis in obese patients with and without hypertension by O.S. Khukhlina, O.E. Mandryk, A.A. Antoniv

Subjects: “…nonalcoholic steatohepatitis…”
Get full text

PREVALENCE AND RISK FACTORS ASSOCIATED WITH NON-ALCOHOLIC STEATOHEPATITIS IN PATIENTS WITH RHEUMATOID ARTHRITIS ON HYDROXYCHLOROQUINE: A POPULATION-BASED STUDY by Antoine BOUSTANY, Somtochukwu ONWUZO, Adejoke JOHNSON, David FARHAT, Mimi NAJJAR, Hadi Khaled Abou ZEID, Chidera N ONWUZO, Mohamad-Noor ABU-HAMMOUR, Rashid ABDEL-RAZEQ, Islam MOHAMED, Barish EREN, Imad ASAAD

Subjects: “…Nonalcoholic steatohepatitis…”
Get full text

Diagnostics of progression of liver fibrosis in patients with non-alcoholic steatohepatitis combined with obesity and chronic calculous cholecystitis. by A. Yu. Filippova

Subjects: “…nonalcoholic steatohepatitis…”
Get full text

CAT and CXCL8 are crucial cofactors for the progression of nonalcoholic steatohepatitis to hepatocellular carcinoma, the immune infiltration and prognosis of hepatocellular carcino... by Liang Yang, Peiping Li, JiaLi Zhao, Zirui Bai, Guifang Zeng, Xialei Liu, Baojia Zou, Jian Li

Subjects: “…Nonalcoholic steatohepatitis…”
Get full text

The impact of the ursodeoxycholic acid as monotherapy and in the combination with the lactulose on the biochemical blood tests values of the nonalcoholic steatohepatitis patients by I. V. Mayev, Yu. A. Kucheryavyy, S. V. Morozov, M. G. Saidullayeva, M. L. Akhtayeva, N. Yu. Stukova, E. A. Krasnyakova

Subjects: “…nonalcoholic steatohepatitis…”
Get full text

Features of the connective tissue metabolism, the content of adipokines and cytokeratin-18 in patients with non-alcoholic steatohepatitis combined with osteoarthritis and obesity by O. S. Khukhlina, O. D. Liakhovych, L. V. Kaniovska, O. V. Kaushanska, V. O. Shuper

Subjects: “…nonalcoholic steatohepatitis…”
Get full text

Non-alcoholic fatty liver disease – a rapidly growing indication for liver transplantation in the modern world by I. M. Iljinsky, O. M. Tsirulnikova

Subjects: Get full text

Nonobese mice with nonalcoholic steatohepatitis fed on a choline‐deficient, l‐amino acid‐defined, high‐fat diet exhibit alterations in signaling pathways by Noriko Suzuki‐Kemuriyama, Akari Abe, Sae Nakane, Kinuko Uno, Shuji Ogawa, Atsushi Watanabe, Ryuhei Sano, Megumi Yuki, Katsuhiro Miyajima, Dai Nakae

Subjects: “…nonalcoholic steatohepatitis…”
Get full text

Global, regional, and national burden of NASH related liver cancer in adults aged 45 and above: an analysis from the GBD 2021 and forecast to 2050 by Jianing Shi, Xuan Wu, Jiali Yu, Qingli Zhou

Subjects: “…nonalcoholic steatohepatitis…”
Get full text

Farnesoid X receptor (FXR) as a potential therapeutic target in nonalcoholic fatty liver disease and associated syndromes by Apollinariya V. Bogolyubova, Alexander Y. Mayorov, Ekaterina E. Mishina, Anton M. Schwartz, Pavel V. Belousov

Subjects: Get full text

Comparative Efficacy of NAFLD Therapies and Biomarker Associations: A Meta-Analysis Based on Liver Fat Content by Haoxiang Zhu, Ling Xu, Yinhua Lv, Juan Yang, Jihan Huang, Qingshan Zheng, Guang Ji, Lujin Li

Subjects: Get full text

Prediction of course and progression of nonalcoholic fatty liver disease in patients with obesity and pathology of the biliary tract with the help of mathematical modeling. by A. Yu. Filippova, I. A. Gubar, V. V. Rudakova

Subjects: Get full text

Possibilities of correction of lipid-phospholipid disorders in patients with non-alcoholic steatohepatitis against obesity and pathology of the biliary tract. by A. Yu. Filippova

Subjects: “…nonalcoholic steatohepatitis…”
Get full text

Methodical approaches in experimental modelling of non-alcoholic fatty liver disease by N. V. Bivalkevich, Yu. K. Denisenko, T. P. Novgorodtseva

Subjects: Get full text

Naringenin attenuates early hepatocarcinogenesis induced by a MASH model by Linda Vanessa Márquez-Quiroga, Aline Barboza-López, Jose Y. Suárez-Castillo, Irina Cardoso-Lezama, Miguel Á. Fuentes-Figueroa, Eduardo E. Vargas-Pozada, Juan D. Rodriguez-Callejas, Erika Ramos-Tovar, Carolina Piña-Vázquez, Jaime Arellanes-Robledo, Saúl Villa-Treviño, Pablo Muriel

Subjects: Get full text

The efficiency of metabolic impact of S-adenosylmethionine and meldonium on parameters of lipid profile and insulin resistance during comorbid course of nonalcocholic steatohepatit... by O. S. Khukhlina, A. A. Antoniv, O. S. Voievidka, O. B. Kuzminska

Subjects: “…nonalcoholic steatohepatitis…”
Get full text

The role of hepatic sinusoidal microenvironment in NASH: pathogenesis, animal models, and therapeutic prospects by Wanying Tan, Jiangting Deng, Jiangting Deng, Lingjun Qi, Zhenghuai Tan

Subjects: “…nonalcoholic steatohepatitis…”
Get full text

TAT as a new marker and its use for noninvasive chemical biopsy in NASH diagnosis by Sihyang Jo, Jin-Mo Kim, Minshu Li, Han Sun Kim, Yong Jin An, Sunghyouk Park

Subjects: “…Nonalcoholic steatohepatitis…”
Get full text

Role of the FOXM1/CMA/ER stress axis in regulating the progression of nonalcoholic steatohepatitis by Shuoyi Ma, Erzhuo Xia, Miao Zhang, Yinan Hu, Siyuan Tian, Xiaohong Zheng, Bo Li, Gang Ma, Rui Su, Keshuai Sun, Qingling Fan, Fangfang Yang, Guanya Guo, Changcun Guo, Yulong Shang, Xinmin Zhou, Xia Zhou, Jingbo Wang, Ying Han

Subjects: Get full text